MARK3 Antikörper (N-Term)
-
- Target Alle MARK3 Antikörper anzeigen
- MARK3 (MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MARK3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from the N-terminal region of Human C-TAK1.
- Isotyp
- IgG
- Top Product
- Discover our top product MARK3 Primärantikörper
-
-
- Applikationshinweise
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:40000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- MARK3 (MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
- Andere Bezeichnung
- MARK3 (MARK3 Produkte)
- Hintergrund
- C-TAK1 antibody, Cdc25C associated protein kinase 1 antibody, Cdc25C-associated protein kinase 1 antibody, cTAK1 antibody, ELKL motif kinase 2 antibody, EMK-2 antibody, Emk2 antibody, ETK 1 antibody, KIAA4230 antibody, KP78 antibody, MAP microtubule affinity regulating kinase 3 antibody, MAP/microtubule affinity-regulating kinase 3 antibody, Mark3 antibody, MARK3_HUMAN antibody, Par 1a antibody, PAR1A antibody, Protein kinase STK10 antibody, Ser/Thr protein kinase PAR-1 antibody, Serine threonine protein kinase p78 antibody, Serine/threonine-protein kinase p78 antibody, SerThr protein kinase PAR 1 antibody
- UniProt
- P27448
- Pathways
- SARS-CoV-2 Protein Interaktom
-